Serum vitamin B12‐binding proteins in a case of eosinophilic leukemia

Charles A. Coltman, Frank Panettiere, Ralph Carmel

Resultado de la investigación: Articlerevisión exhaustiva

6 Citas (Scopus)


A patient with subacute eosinophilic leukemia is presented, with full recognition of the controversy surrounding that entity. Serum vitamin B12 and B12 ‐binding protein studies and simultaneous complete blood counts were done before and during 6 months of high‐dose, intermittent combination chemotherapy. The patient presented with extremely high levels of serum vitamin B12, unsaturated B12‐binding capacity, and transcobalamin I, all of which resembled the highest values seen in chronic myelogenous leukemia. Serial studies, during and after remission induction, showed a precipitous fall of serum vitamin B12 and unsaturated B12‐binding capacity to normal levels. The data show that transcobalamin I levels, which eventually reached low‐normal range, correlate best with the level of circulating and bone marrow eosinophils. Transcobalamin II and serum third binder appeared to be normal throughout the patient's course. The B12‐binding protein abnormalities are not considered diagnostic of eosinophilic leukemia.

Idioma originalEnglish (US)
Páginas (desde-hasta)185-193
Número de páginas9
PublicaciónMedical and Pediatric Oncology
EstadoPublished - 1975
Publicado de forma externa

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Cancer Research


Profundice en los temas de investigación de 'Serum vitamin B12‐binding proteins in a case of eosinophilic leukemia'. En conjunto forman una huella única.

Citar esto